跳至主要内容
临床试验/NL-OMON34478
NL-OMON34478招募中不适用

The FIBRINOGEN study; to evaluate and compare the ex vivo effects of recombinant human fibrinogen (rhFGN) , variants rhFbgAa610 and Aa847, and Haemocomplettan supplementation on blood coagulation - FIBRINOGEN study

eids Universitair Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Coronary artery bypass graft (CABG), isolated and on-pump
  • - Preoperative fibrinogen level <3,8g/L
  • - Left ventricle ejection fraction > 35%
  • - Age >18 years

排除标准

  • - Any other procedure than on-pump CABG
  • - Preoperative fibrinogen level >3,8g/L
  • - Emergency surgery
  • - History of bleeding diathesis or coagulopathy
  • - Participation in any study involving an investigational drug or device
  • - Inability to understand the study information and/or sign informed consent
  • - Usage of FFPs or fibrinogen before or during the CABG procedure

研究者

相似试验